AZGP1 and cancer: Zinc-α2-glycoprotein (ZAG, also known as AZGP1), a newly identified adipokine, was initially shown to be a tumor-derived molecule (Todorov et al., 1998) responsible for loss of fat mass in patients with cancer cachexia through its action as a lipid-mobilizing factor (Hirai et al., 1998).